Use of amplified fragment length polymorphism analysis to identify medically important Candida spp., including C. dubliniensis. | J Clin Microbiol;41(4): 1357-62, 2003 Apr. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Use of amplified fragment length polymorphism analysis to identify medically important Candida spp., including C. dubliniensis.

Borst, A; Theelen, B; Reinders, E; Boekhout, T; Fluit, A C; Savelkoul, P H M.

Affiliation

Borst A; Eijkman-Winkler Center for Microbiology, Infectious Diseases and Inflammation, University Medical Center, Utrecht, The Netherlands. aoz0@cdc.gov

J Clin Microbiol ; 41(4): 1357-62, 2003 Apr.

Article in En | MEDLINE | ID: mdl-12682114

Subject(s)

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Polymorphism, Restriction Fragment Length / Candida / Candidiasis Type of study: Evaluation_studies Limits: Humans Language: En Journal: J Clin Microbiol Year: 2003 Document type: Article Affiliation country: Country of publication:

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Polymorphism, Restriction Fragment Length / Candida / Candidiasis Type of study: Evaluation_studies Limits: Humans Language: En Journal: J Clin Microbiol Year: 2003 Document type: Article Affiliation country: Country of publication: